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in dermis, consisting of lymphocytes, plasma cells, 
and neutrophils; the diagnosis of interfaced derma-
titis was established (Figure 1, d, e). After one month, 
the patient presented to our clinic with numerous 
nodular lesions, some of them painful, located on the 
trunk and intertriginous folds, including the interglu-
teal cleft – the lesions in this area being suggestive 
of condylomata lata (Figure 1, c). The diagnosis of 
secondary syphilis was taken into consideration, and 
screening serum tests were performed and found 
reactive: a Venereal Diseases Research Laboratory 
(VDRL) titer of 1:64 and Treponema pallidum Hema-
glutination Assay (TPHA) titer of 1:80. Hepatitis and 
anti-human immunodeficiency virus (HIV) antibod-
ies serology was negative. The biopsy was repeated 
and showed the same histopathological changes. In 
addition, Warthin-Starry staining was performed, re-
vealing the presence of some spiral micro-organisms 
in the dermis corresponding to Treponema pallidum 
(Figure 1, f ). 
Figure 1. Case 1; clinical manifestations: nodular lesion on the face (a); nodular lesions in the axillary fold (b); condylomata 
lata (c); histopathology (hematoxylin and eosin (HE) ×20): epidermal hyperplasia with papillomatosis; (d) HE ×40: inflamma-
tory infiltrate in the dermis consisting of lymphocytes, plasma cells, and neutrophils; (e) HE ×40: Warthin-Starry staining: the 
presence of Treponema pallidum; (f )
Dear Editor,
Syphilis is an infection caused by Treponema pal-
lidum. Without treatment, it goes through the follow-
ing stages: primary, secondary, latent, and tertiary 
(1). The clinical picture of secondary syphilis is very 
variable (2,3). We present two rare cases of secondary 
syphilis, one with nodular lesions initially considered 
to be lymphoma and second with periostitis, which 
was initially interpreted as an osteoma. To date, only 
15 cases with nodular lesions and 10 cases with peri-
ostitis in secondary syphilis have been reported in 
the literature.
The first patient was a 59 year old man who pre-
sented in a private practice with nodular lesions on 
the face and axillary and inguinal folds (Figure 1, a, b). 
The initial diagnostic consideration was lymphoma. 
A biopsy specimen was taken, and the histopatho-
logical features revealed epidermal hyperplasia with 
papillomatosis, minimal spongiosis with many neu-
trophils and with a marked inflammatory infiltrate 
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A diagnosis of secondary syphilis was established, 
and the patient was treated with benzathine penicil-
lin G 2.4 million units by intramuscular injection once 
a week for 2 consecutive weeks. The skin lesions re-
gressed within 1 month, and serological tests showed 
a VDRL titer of 1:8 3 months after treatment.
The second patient was a homosexual male, 35 
years old, diagnosed with HIV infection, stage B2. He 
presented with bone pain in the calves and forearms, 
with insidious onset. He also presented with an as-
sociated erythematous maculo-papular rash on the 
trunk and limbs and generalized lymphadenopathy 
(Figure 2, a, b). The tibial crest and radius were sen-
sitive to palpation. A right leg radiography was per-
formed, raising suspicion of osteoid osteoma. The CT 
scan excluded the diagnosis of osteoma; taking into 
account the epidemiological context, the diagnosis 
of syphilis was suspected. The diagnosis was con-
firmed by leg ultrasound examination (2D US) which 
showed thickening of the compact tibial bone associ-
ated with subperiosteal destructive and proliferative 
changes (Figure 2, c, d) and by serology for syphilis: 
the VDRL titer was 1:32 and the TPHA titer was 1:80. 
The patient was treated with benzathine penicillin 2.4 
million units, once a week, for 2 consecutive weeks, 
with clinical improvement.
Syphilis continues to be a serious public health 
problem worldwide, even if it is a controllable disease 
due to diagnostic tests and effective and accessible 
treatment.
According to the World Health Organization in 
2008, the estimated number of new cases of sexu-
ally transmitted diseases in adults with syphilis is 10.6 
million cases (4).  
The cases presented in this paper were charac-
terized by unusual manifestations, requiring good 
collaboration between the dermatologist and other 
specialties. 
In the first case, the diagnosis of secondary syphi-
lis was confirmed by positive serological, clinical, and 
histopathological findings. The main differential di-
agnosis of nodular syphilis includes lymphoma, sar-
coidosis, Kaposi’s sarcoma, atypical mycobacteriosis, 
deep fungal infections, leprosy, tuberculosis, leish-
maniasis, and lymphomatoid papulosis (5). Another 
important differential diagnosis is between second-
ary and tertiary syphilis, especially when ulcerating 
nodules are present. Tertiary syphilis is characterized 
by unilateral, deep ulcerating nodules with necrotiz-
ing granulomas (6). 
Bone involvement during syphilis is mainly repre-
sented by polyarthritis, synovitis, osteitis, and perios-
titis (7,8). Syphilitic periostitis is characterized by lo-
calized or diffuse pain, particularly during the night, 
which is relieved by movement. The skull, the shoul-
der girdle, and the long bones are the most common 
sites of involvement (9). 
In conclusion, we presented two different cases of 
secondary syphilis that contribute to the clinical expe-
rience of rare cases presented in the literature, raising 
the awareness of dermatologists and other specialists 
about less specific clinical aspects of syphilis.
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